The system expects its operating results for the fourth quarter of 2014 to “reflect a 56.4 percent increase in total admissions and a 58.2 percent increase in adjusted admissions compared with the same period in 2013.”
CHS expects its net operating revenues for the three months ended Dec. 31, 2014 to be approximately $4.9 billion, which is a $1.7 billion increase over the system’s operating revenues for the same period in 2013. The increase in revenue was largely attributable to CHS’ acquisition of Naples, Fla.-based Health Management Associates.
However, CHS’ expected operating revenues for the fourth quarter of 2014 fall slightly below analysts’ expectations of $5 billion.
The system expects adjusted EBITDA for the fourth quarter of fiscal 2014 to be about $785 million, an increase of 71 percent over adjusted EBITDA of $459 million for the same period in 2013.
More articles on healthcare finance:
Cadence merger gives Northwestern Memorial Healthcare’s margins a boost
For-profit hospital stock report: Week of Jan. 12-16
Erlanger posts ‘unprecedented’ $12.7M profit
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
